GlassScriptPhysician profile
Jeffrey Eugene Wheeler
NPI 1174562748
$299.38
in general payments reported to CMS, 2019-2025
11 companies · $46.24 in 2025
The $46.24 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $3.33 · 2021: $33.35 · 2022: $43.28 · 2023: $38.19 · 2024: $28.09 · 2025: $46.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $49.43 | 2019-2023 | Krystexxa |
| Janssen Pharmaceuticals, INC | $38.98 | 2019 | |
| Orthofix Medical, INC. | $32.07 | 2019-2020 | |
| Smith+Nephew, INC. | $31.60 | 2022-2025 | Renasys Go V2 Home |
| Bioventus LLC | $30.26 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $28.94 | 2025 | Inceptiv |
| Abbott Laboratories | $25.72 | 2019 | |
| Apria Healthcare LLC | $18.60 | 2021 | |
| Averitas Pharma INC. | $15.25 | 2023 | Qutenza |
| Organogenesis INC. | $14.75 | 2021 | |
| Nevro Corp. | $13.78 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.